Global and Region Breast Cancer Predictive Genetic Testing Market Demand & Opportunity Outlook 2022-2028

  • REPORT SUMMARY
  • TABLE OF CONTENTS
  • The report details the trend, potential and market size of Breast Cancer Predictive Genetic Testing market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.

    The first part (Chapter1-7) mainly covers the qualitative analysis of Breast Cancer Predictive Genetic Testingmarket, defines the market attractiveness level of Breast Cancer Predictive Genetic Testing market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.

    The second part (Chapter8-12), based on the segmentation of Breast Cancer Predictive Genetic Testing industry, describes the types of Breast Cancer Predictive Genetic Testing market, the applications of major players and the market size, and deeply analyzes the current situation of the global Breast Cancer Predictive Genetic Testing market and the development prospects and opportunities of Breast Cancer Predictive Genetic Testing industry.

    The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.

    As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Breast Cancer Predictive Genetic Testing market in Chapter 13.

    By Player:

    • Thermo Fisher Scientific

    • Iverson Genetics

    • Roche

    • PerkinElmer

    • Cancer Genetics

    • Invitae

    • OncoCyte Corporation

    • Myriad Genetics

    • NeoGenomics

    • Quest Diagnostics

    By Type:

    • High Penetrant Genes

    • Intermediate Penetrant Genes

    • Low Penetrant Genes

    By End-User:

    • Hospitals

    • Clinics

    • Other

    By Geography:

    • United States

    • Europe

    • China

    • Japan

    • India

    • South Korea

  • TABLE OF CONTENT

    1 Introduction

    • 1.1 Market Definition

    • 1.2 Market Segment Analysis

    • 1.3 Market Size 2022

    • 1.4 Breast Cancer Predictive Genetic Testing Market Outlook: Forecast for 2022 - 2028

    • 1.5 Pricing Analysis

    2 Executive Summary

    3 Breast Cancer Predictive Genetic Testing Market Lineage Outlook

    • 3.1 Parent Market Outlook

    • 3.2 Related/Ancillary Market Outlook

    • 3.3 Penetration & Growth Prospect Mapping, 2022

    4 Market Analysis Tools: Porter's Five Forces

    • 4.1 Supplier Power

    • 4.2 Buyer Power

    • 4.3 Substitution Threat

    • 4.4 Threat of New Entrants

    • 4.5 Competitive Rivalry

    5 Breast Cancer Predictive Genetic Testing Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)

    • 5.1 Political/Legal Landscape

    • 5.2 Economic Landscape

    • 5.3 Social Landscape

    • 5.4 Technology Landscape

    6 Breast Cancer Predictive Genetic Testing Market - Value Chain Analysis

    • 6.1 Industry's Value Chain Analysis

    • 6.2 Product Life Cycle

    • 6.3 User Perspective Analysis

    7 Region and Country-wise Breast Cancer Predictive Genetic Testing Market Analysis and Outlook to 2022

    • 7.1 Global Breast Cancer Predictive Genetic Testing Consumption (2017-2022)

    • 7.2 United States Breast Cancer Predictive Genetic Testing Consumption (2017-2022)

    • 7.3 Europe Breast Cancer Predictive Genetic Testing Consumption (2017-2022)

    • 7.4 China Breast Cancer Predictive Genetic Testing Consumption (2017-2022)

    • 7.5 Japan Breast Cancer Predictive Genetic Testing Consumption (2017-2022)

    • 7.6 India Breast Cancer Predictive Genetic Testing Consumption (2017-2022)

    • 7.7 South Korea Breast Cancer Predictive Genetic Testing Consumption (2017-2022)

    8 Region and Country-wise Breast Cancer Predictive Genetic Testing Market Analysis and Outlook to 2028

    • 8.1 Global Breast Cancer Predictive Genetic Testing Consumption Forecast (2022-2028)

    • 8.2 United States Breast Cancer Predictive Genetic Testing Consumption Forecast (2022-2028)

    • 8.3 Europe Breast Cancer Predictive Genetic Testing Consumption Forecast (2022-2028)

    • 8.4 China Breast Cancer Predictive Genetic Testing Consumption Forecast (2022-2028)

    • 8.5 Japan Breast Cancer Predictive Genetic Testing Consumption Forecast (2022-2028)

    • 8.6 India Breast Cancer Predictive Genetic Testing Consumption Forecast (2022-2028)

    • 8.7 South Korea Breast Cancer Predictive Genetic Testing Consumption Forecast (2022-2028)

    9 Global Breast Cancer Predictive Genetic Testing Market Outlook by Types and Applications to 2022

    • 9.1 Global Breast Cancer Predictive Genetic Testing Consumption and Growth Rate by Type (2017-2022)

      • 9.1.1 Global High Penetrant Genes Consumption and Growth Rate (2017-2022)

      • 9.1.2 Global Intermediate Penetrant Genes Consumption and Growth Rate (2017-2022)

      • 9.1.3 Global Low Penetrant Genes Consumption and Growth Rate (2017-2022)

    • 9.2 Global Breast Cancer Predictive Genetic Testing Consumption and Growth Rate by Application (2017-2022)

      • 9.2.1 Global Hospitals Consumption and Growth Rate (2017-2022)

      • 9.2.2 Global Clinics Consumption and Growth Rate (2017-2022)

      • 9.2.3 Global Other Consumption and Growth Rate (2017-2022)

    10 Global Breast Cancer Predictive Genetic Testing Market Outlook by Types and Applications to 2028

    • 10.1 Global Breast Cancer Predictive Genetic Testing Consumption Forecast and Growth Rate by Type (2022-2028)

      • 10.1.1 Global High Penetrant Genes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.2 Global Intermediate Penetrant Genes Consumption Forecast and Growth Rate (2022-2028)

      • 10.1.3 Global Low Penetrant Genes Consumption Forecast and Growth Rate (2022-2028)

    • 10.2 Global Breast Cancer Predictive Genetic Testing Consumption Forecast and Growth Rate by Application (2022-2028)

      • 10.2.1 Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.2 Global Clinics Consumption Forecast and Growth Rate (2022-2028)

      • 10.2.3 Global Other Consumption Forecast and Growth Rate (2022-2028)

    11 Global Breast Cancer Predictive Genetic Testing Import and Export Analysis (Top 5 Countries)

    • 11.1 Global Breast Cancer Predictive Genetic Testing Import by Region (Top 5 Countries) (2017-2028)

    • 11.2 Global Breast Cancer Predictive Genetic Testing Export by Region (Top 5 Countries) (2017-2028)

    12 Coronavirus Disease (COVID-19) Impact

    • 12.1 Industry Impact Analysis

    • 12.2 Breast Cancer Predictive Genetic Testing Market Outlook to 2028 - COVID-19 Affected Forecasts

    13 Competition Matrix

    • 13.1 Target Markets

    • 13.2 Comprehensive Analysis of Products in Competitive Markets

    14 Global Breast Cancer Predictive Genetic Testing Market Competitive Analysis

    • 14.1 Thermo Fisher Scientific

      • 14.1.1 Thermo Fisher Scientific Company Details

      • 14.1.2 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.1.3 Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Product and Service

    • 14.2 Iverson Genetics

      • 14.2.1 Iverson Genetics Company Details

      • 14.2.2 Iverson Genetics Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.2.3 Iverson Genetics Breast Cancer Predictive Genetic Testing Product and Service

    • 14.3 Roche

      • 14.3.1 Roche Company Details

      • 14.3.2 Roche Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.3.3 Roche Breast Cancer Predictive Genetic Testing Product and Service

    • 14.4 PerkinElmer

      • 14.4.1 PerkinElmer Company Details

      • 14.4.2 PerkinElmer Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.4.3 PerkinElmer Breast Cancer Predictive Genetic Testing Product and Service

    • 14.5 Cancer Genetics

      • 14.5.1 Cancer Genetics Company Details

      • 14.5.2 Cancer Genetics Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.5.3 Cancer Genetics Breast Cancer Predictive Genetic Testing Product and Service

    • 14.6 Invitae

      • 14.6.1 Invitae Company Details

      • 14.6.2 Invitae Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.6.3 Invitae Breast Cancer Predictive Genetic Testing Product and Service

    • 14.7 OncoCyte Corporation

      • 14.7.1 OncoCyte Corporation Company Details

      • 14.7.2 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.7.3 OncoCyte Corporation Breast Cancer Predictive Genetic Testing Product and Service

    • 14.8 Myriad Genetics

      • 14.8.1 Myriad Genetics Company Details

      • 14.8.2 Myriad Genetics Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.8.3 Myriad Genetics Breast Cancer Predictive Genetic Testing Product and Service

    • 14.9 NeoGenomics

      • 14.9.1 NeoGenomics Company Details

      • 14.9.2 NeoGenomics Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.9.3 NeoGenomics Breast Cancer Predictive Genetic Testing Product and Service

    • 14.10 Quest Diagnostics

      • 14.10.1 Quest Diagnostics Company Details

      • 14.10.2 Quest Diagnostics Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

      • 14.10.3 Quest Diagnostics Breast Cancer Predictive Genetic Testing Product and Service

    15 Appendix


    TABLE OF CHARTS

    • Table Definition of Breast Cancer Predictive Genetic Testing

    • Figure Breast Cancer Predictive Genetic Testing Picture

    • Table Global Breast Cancer Predictive Genetic Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Breast Cancer Predictive Genetic Testing Market Size and Forecast 2022 - 2028 (USD million)

    • Figure Global Breast Cancer Predictive Genetic Testing Market: Year-over-year Growth 2022 - 2028 (%)

    • Table Parent Market Analysis

    • Figure Parent Market Price

    • Table Related/Ancillary Market Outlook Analysis

    • Table Supplier Power Analysis

    • Table Buyer Power Analysis

    • Table Substitution Threat Analysis

    • Table Threat of New Entrants Analysis

    • Table Competitive Rivalry Analysis

    • Figure Global Breast Cancer Predictive Genetic Testing Consumption by Country (2017-2022)

    • Figure United States Breast Cancer Predictive Genetic Testing Consumption and Growth Rate (2017-2022)

    • Table Europe Breast Cancer Predictive Genetic Testing Consumption and Growth Rate (2017-2022)

    • Figure China Breast Cancer Predictive Genetic Testing Consumption and Growth Rate (2017-2022)

    • Figure Japan Breast Cancer Predictive Genetic Testing Consumption and Growth Rate (2017-2022)

    • Figure India Breast Cancer Predictive Genetic Testing Consumption and Growth Rate (2017-2022)

    • Figure South Korea Breast Cancer Predictive Genetic Testing Consumption and Growth Rate (2017-2022)

    • Figure Global Breast Cancer Predictive Genetic Testing Consumption Forecast by Country (2022-2028)

    • Figure United States Breast Cancer Predictive Genetic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Table Europe Breast Cancer Predictive Genetic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure China Breast Cancer Predictive Genetic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Japan Breast Cancer Predictive Genetic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure India Breast Cancer Predictive Genetic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure South Korea Breast Cancer Predictive Genetic Testing Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global High Penetrant Genes Consumption and Growth Rate (2017-2022)

    • Figure Global Intermediate Penetrant Genes Consumption and Growth Rate (2017-2022)

    • Figure Global Low Penetrant Genes Consumption and Growth Rate (2017-2022)

    • Figure Global Hospitals Consumption and Growth Rate (2017-2022)

    • Figure Global Clinics Consumption and Growth Rate (2017-2022)

    • Figure Global Other Consumption and Growth Rate (2017-2022)

    • Figure Global High Penetrant Genes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Intermediate Penetrant Genes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Low Penetrant Genes Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Hospitals Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Clinics Consumption Forecast and Growth Rate (2022-2028)

    • Figure Global Other Consumption Forecast and Growth Rate (2022-2028)

    • Table Global Breast Cancer Predictive Genetic Testing Import by Region (Top 5 Countries) (2017-2028)

    • Table Global Breast Cancer Predictive Genetic Testing Export by Region (Top 5 Countries) (2017-2028)

    • Table Thermo Fisher Scientific (Foundation Year, Company Profile and etc.)

    • Table Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Thermo Fisher Scientific Breast Cancer Predictive Genetic Testing Product and Service

    • Table Iverson Genetics (Foundation Year, Company Profile and etc.)

    • Table Iverson Genetics Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Iverson Genetics Breast Cancer Predictive Genetic Testing Product and Service

    • Table Roche (Foundation Year, Company Profile and etc.)

    • Table Roche Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Roche Breast Cancer Predictive Genetic Testing Product and Service

    • Table PerkinElmer (Foundation Year, Company Profile and etc.)

    • Table PerkinElmer Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table PerkinElmer Breast Cancer Predictive Genetic Testing Product and Service

    • Table Cancer Genetics (Foundation Year, Company Profile and etc.)

    • Table Cancer Genetics Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Cancer Genetics Breast Cancer Predictive Genetic Testing Product and Service

    • Table Invitae (Foundation Year, Company Profile and etc.)

    • Table Invitae Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Invitae Breast Cancer Predictive Genetic Testing Product and Service

    • Table OncoCyte Corporation (Foundation Year, Company Profile and etc.)

    • Table OncoCyte Corporation Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table OncoCyte Corporation Breast Cancer Predictive Genetic Testing Product and Service

    • Table Myriad Genetics (Foundation Year, Company Profile and etc.)

    • Table Myriad Genetics Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Myriad Genetics Breast Cancer Predictive Genetic Testing Product and Service

    • Table NeoGenomics (Foundation Year, Company Profile and etc.)

    • Table NeoGenomics Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table NeoGenomics Breast Cancer Predictive Genetic Testing Product and Service

    • Table Quest Diagnostics (Foundation Year, Company Profile and etc.)

    • Table Quest Diagnostics Breast Cancer Predictive Genetic Testing Sales, Price, Value and Gross Profit (2017-2022)

    • Table Quest Diagnostics Breast Cancer Predictive Genetic Testing Product and Service


Report Version Choose

Report

BUY NOW

Our Customers

Beyond grateful for the confidence and support from all partners and customers.A win-win situation is our ultimate pursuit.

Beyond Consulting, Future is Feasible

We provide more professional and intelligent market reports to complement your business decisions.